海外の治験の状況「1」での検索結果
860件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 地域
- 登録日
Not recruiting
- Comparison of Insulin Detemir Plus Insulin Aspart With Insulin NPH Plus Human Soluble Insulin in Subjects With Type 1 Diabetes
- Diabetes;Diabetes Mellitus, Type 1;Diabetes;Diabetes Mellitus, Type 1;Diabetes;Diabetes Mellitus, Type 1;Diabetes;Diabetes Mellitus, Type 1
- Argentina, Croatia, Czech Republic, Denmark, Finland, France, Greece, Italy, Macedonia, The Former Yugoslav Republic of, Norway, Poland, Romania, Russian Federation, Slovakia, Sweden
- 2011-12-05
Not recruiting
- Safety and Efficacy Study of Daclatasvir (BMS-790052) Plus Pegylated Interferon-Alfa 2a and Ribavirin in Patients Coinfected With Untreated Hepatitis C Virus and HIV Virus
- Hepatitis C, Genotype 1;Hepatitis C, Genotype 1;Hepatitis C, Genotype 1;Hepatitis C, Genotype 1
- Argentina, Australia, Belgium, Brazil, Canada, France, Germany, Italy, Puerto Rico, Russian Federation, Spain, United Kingdom, United States
- 2011-11-04
Not recruiting
- Efficacy and Safety of Insulin Aspart vs. Human Insulin During Pregnancy by Women With Type 1 Diabetes
- Diabetes;Diabetes Mellitus, Type 1
- Argentina, Austria, Bulgaria, Canada, Croatia, Denmark, Finland, France, Germany, Greece, Ireland, Israel, Netherlands, Norway, Poland, Russian Federation, Spain, United Kingdom
- 2006-08-10
Not recruiting
- A 2-Month Safety Follow-Up Trial
- Type 1 Diabetes;Type 2 Diabetes
- Brazil, Canada, Russian Federation, United States
- 2008-08-22
Not recruiting
- Comparison of Insulin Detemir With NPH Insulin in Type 1 Diabetes
- Diabetes;Diabetes Mellitus, Type 1;Diabetes;Diabetes Mellitus, Type 1;Diabetes;Diabetes Mellitus, Type 1;Diabetes;Diabetes Mellitus, Type 1
- Argentina, Australia, Bulgaria, Croatia, India, Macedonia, The Former Yugoslav Republic of, Malaysia, Romania, South Africa, Turkey
- 2005-09-13
Not Recruiting
- Phase II trial of oral vinorelbine in a population of patients with lung cancer with an EGFR mutation, after failure to treatment with TKI in first line.
- Patients with: -Histologically or cytologically confirmed NSCLC (stage IIIB or IV) and -epidermal growth factor receptor (EGFR) positive mutation and -previously treated with tyrosine kinase inhibitor (gefitinib or erlotinib) MedDRA version: 14.1 Level: PT Classification code 10029522 Term: Non-small cell lung cancer stage IV System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) MedDRA version: 14.1 Level: PT Classification code 10029521 Term: Non-small cell lung cancer stage IIIB System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) MedDRA version: 14.1 Level: PT Classification code 10029515 Term: Non-small cell lung cancer recurrent System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) ;Therapeutic area: Diseases [C] - Cancer [C04]
- Argentina, Austria, Poland, Singapore, Taiwan
- 2012-12-03
Not recruiting
- Comparative Efficacy and Safety Study of Dolutegravir and Lopinavir/Ritonavir in Second-line Treatment
- Infection, Human Immunodeficiency Virus
- Argentina, Brazil, Chile, China, Colombia, Kenya, Mexico, Peru, Romania, Russian Federation, South Africa, Thailand, Ukraine
- 2014-08-25
Not recruiting
- Impact Evaluation of the 123 Women Emergency Phone Line in Medellín, Colombia
- Violence Against Women (VAW);Violence Against Women (VAW);Violence Against Women (VAW);Violence Against Women (VAW)
- Colombia
- 2014-06-03
Not recruiting
- Bioequivalence Study Bevacizumab Biosimilar (BEVZ92) Versus Bevacizumab (AVASTIN®) in First-line Treatment mCRC Patients
- Metastatic Colorectal Cancer
- Argentina, Brazil, India, Peru, Russian Federation, Spain, Ukraine
- 2014-02-14
Not recruiting
- An Open-Label, Randomized, Phase 3 Trial of Nivolumab Versus Investigator's Choice Chemotherapy as First-Line Therapy for Stage IV or Recurrent PD-L1+ Non-Small Cell Lung Cancer (CheckMate 026)
- Stage IV or Recurrent Non-Small Cell Lung Cancer;Stage IV or Recurrent Non-Small Cell Lung Cancer;Stage IV or Recurrent Non-Small Cell Lung Cancer;Stage IV or Recurrent Non-Small Cell Lung Cancer
- Argentina, Australia, Austria, Belgium, Brazil, Canada, Czech Republic, Czechia, Finland, France, Germany, Greece, Hungary, Italy, Japan, Korea, Republic of, Mexico, Netherlands, Poland, Romania, Spain, Sweden, Switzerland, Taiwan, Turkey, United Kingdom, United States
- 2014-01-19
